Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
- PMID: 31581676
- PMCID: PMC6827161
- DOI: 10.3390/cancers11101484
Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
Abstract
Anaplastic large cell lymphoma (ALCL) and classical Hodgkin lymphoma (cHL) are lymphomas that contain CD30-expressing tumor cells and have numerous pathological similarities. Whereas ALCL is usually diagnosed at an advanced stage, cHL more frequently presents with localized disease. The aim of the present study was to elucidate the mechanisms underlying the different clinical presentation of ALCL and cHL. Chemokine and chemokine receptor expression were similar in primary ALCL and cHL cases apart from the known overexpression of the chemokines CCL17 and CCL22 in the Hodgkin and Reed-Sternberg (HRS) cells of cHL. Consistent with the overexpression of these chemokines, primary cHL cases encountered a significantly denser T cell microenvironment than ALCL. Additionally to differences in the interaction with their microenvironment, cHL cell lines presented a lower and less efficient intrinsic cell motility than ALCL cell lines, as assessed by time-lapse microscopy in a collagen gel and transwell migration assays. We thus propose that the combination of impaired basal cell motility and differences in the interaction with the microenvironment hamper the dissemination of HRS cells in cHL when compared with the tumor cells of ALCL.
Keywords: anaplastic large cell lymphoma; cell motility; chemokine receptors; classical Hodgkin lymphoma; dissemination; gene expression; image analysis; rosetting T cells; segmentation.
Conflict of interest statement
The authors report no potential conflict of interest.
Figures





References
-
- Swerdlow S.H., Campo E., Harris N.L., Jaffee E.S., Pileri S.A., Stein H., Thiele J., Arber D.A., Hasserjian R.P., Le Beau M.M., et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer; Lyon, France: 2017.
-
- Stein H., Mason D.Y., Gerdes J., O’Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H., et al. The Expression of the Hodgkin’s Disease Associated Antigen Ki-1 in Reactive and Neoplastic Lymphoid Tissue: Evidence that Reed-Sternberg Cells and Histiocytic Malignancies are Derived from Activated Lymphoid Cells. Blood. 1985;66:848–858. - PubMed
-
- Sarris A.H., Luthra R., Papadimitracopoulou V., Waasdorp M., Dimopoulos M.A., McBride J.A., Cabanillas F., Duvic M., Deisseroth A., Morris S.W., et al. Amplification of Genomic DNA Demonstrates the Presence of the t(2;5) (p23;q35) in Anaplastic Large Cell Lymphoma, but not in other non-Hodgkin’s Lymphomas, Hodgkin’s Disease, or Lymphomatoid Papulosis. Blood. 1996;88:1771–1779. - PubMed
-
- Stein H., Foss H.D., Durkop H., Marafioti T., Delsol G., Pulford K., Pileri S., Falini B. CD30(+) anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features. Blood. 2000;96:3681–3695. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources